PDS Biotechnology (PDSB)
(Delayed Data from NSDQ)
$3.42 USD
+0.11 (3.32%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.43 +0.01 (0.29%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (86 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.37 | 9.99 |
Current Quarter Estimate | -0.29 | 2.59 | 63.00 |
Year Ago Quarter Estimate | -0.35 | -4.98 | 52.25 |
Next Quarter Estimate | -0.33 | 3.37 | 66.00 |
Next Year Estimate | -1.34 | 23.17 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.79 | 17.40 | 15.67 |
Next Year | -8.06 | 10.10 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.28 |
Price/Book (MRQ) | 4.06 | 1.97 |
Price/Cash Flow (MRFY) | NA | 15.50 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -101.26% |
Return on Equity (TTM) | -137.06% | -60.58% |
Debt to Equity (MRQ) | NA | 8.58 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.